Intrinsic excitability changes induced by acute treatment of hippocampal CA1 pyramidal neurons with exogenous amyloid β peptide

Hippocampus

Volumn 25, Issue 7, 2015, Pages 786-797

  Tamagnini, Francesco ^a,b   Scullion, Sarah ^b   Brown, Jon T ^a,b   Randall, Andrew D ^a,b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloidopathy; Hippocampus; Hyperexcitability; Membrane properties

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ACTION POTENTIAL; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CURRENT CLAMP TECHNIQUE; HIPPOCAMPAL CA1 REGION; HYPERPOLARIZATION; IN VITRO STUDY; MALE; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TRANSGENIC MOUSE; ANALYSIS OF VARIANCE; ANIMAL; BIOPHYSICS; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; ELECTROSTIMULATION; HUMAN; NERVE CELL NETWORK; PATCH CLAMP TECHNIQUE;

ACTION POTENTIALS; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; BIOPHYSICS; CA1 REGION, HIPPOCAMPAL; ELECTRIC STIMULATION; HUMANS; IN VITRO TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; NERVE NET; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PYRAMIDAL CELLS;

EID: 84931086275     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22403     Document Type: Article

References (43)

1. An K, Klyubin I, Kim Y, Jung JH, Mably AJ, O'Dowd ST, Lynch T, Kanmert D, Lemere CA, Finan GM, et al. 2013. Exosomes neutralize synaptic-plasticity-disrupting activity of A beta assemblies in vivo. Mol Brain 6:47.
2. Brouillette J, Caillierez R, Zommer N, Alves-Pires C, Benilova I, Blum D, De Strooper B, Buee L. 2012. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-beta1-42 oligomers are revealed in vivo by using a novel animal model. J Neurosci 32:7852-7861.
3. Brown JT, Chin J, Leiser SC, Pangalos MN, Randall AD. 2011. Altered intrinsic neuronal excitability and reduced Na+ currents in a mouse model of Alzheimer's disease. Neurobiol Aging 32:2109.e1-e14.
4. Brown JT, Randall AD. 2009. Activity-dependent depression of the spike after-depolarization generates long-lasting intrinsic plasticity in hippocampal CA3 pyramidal neurons. J Physiol 587:1265-1281.
5. Chow VW, Mattson MP, Wong PC, Gleichmann M. 2010. An overview of APP processing enzymes and products. Neuromol Med 12:1-12.
6. Citron M. 2004. Beta-secretase inhibition for the treatment of Alzheimer's disease-Promise and challenge. Trends Pharmacol Sci 25:92-97.
7. Cullen WK, Suh YH, Anwyl R, Rowan MJ. 1997. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 8:3213-3217.
8. Cullen WK, Wu J, Anwyl R, Rowan MJ. 1996. Beta-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. Neuroreport 8:87-92.
9. Fitzjohn SM, Doherty AJ, Collingridge GL. 2008. The use of the hippocampal slice preparation in the study of Alzheimer's disease. Eur J Pharmacol 585:50-59.
10. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
11. Hardy JA, Higgins GA. 1992. Alzheimer's disease: The amyloid cascade hypothesis. Science 256:184-185.
12. Hazra A, Gu F, Aulakh A, Berridge C, Eriksen JL, Ziburkus J. 2013. Inhibitory neuron and hippocampal circuit dysfunction in an aged mouse model of Alzheimer's disease. PLoS One 8:e64318.
13. Hoxha E, Boda E, Montarolo F, Parolisi R, Tempia F. 2012. Excitability and synaptic alterations in the cerebellum of APP/PS1 mice. PLoS One 7:e34726.
14. Hu H, Vervaeke K, Storm JF. 2002. Two forms of electrical resonance at theta frequencies, generated by M-current, h-current and persistent Na+ current in rat hippocampal pyramidal cells. J Physiol 545:783-805.
15. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, et al. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103:5161-5166.
16. Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, Dickinson B, Scullion S, Sheng M, Collingridge G, et al. 2011. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat Neurosci 14:545-547.
17. Kaczorowski CC, Sametsky E, Shah S, Vassar R, Disterhoft JF. 2011. Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease. Neurobiol Aging 32:1452-1465.
18. Kerrigan TL, Brown JT, Randall AD. 2013. Characterization of altered intrinsic excitability in hippocampal CA1 pyramidal cells of the Abeta-overproducing PDAPP mouse. Neuropharmacology 79:515-524.
19. Klyubin I, Ondrejcak T, Hayes J, Cullen WK, Mably AJ, Walsh DM, Rowan MJ. 2013. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Abeta in vivo. Philos Trans R Soc Lond B Biol Sci 369:20130147.
20. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, et al. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
21. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. 2009. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128-1132.
22. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801.
23. Lithner CU, Hedberg MM, Nordberg A. 2011. Transgenic mice as a model for Alzheimer's disease. Curr Alzheimer Res 8:818-831.
24. Luebke JI, Amatrudo JM. 2012. Age-related increase of sI(AHP) in prefrontal pyramidal cells of monkeys: Relationship to cognition. Neurobiol Aging 33:1085-1095.
25. Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, Klann E. 2011. Amyloid beta-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci 31:5589-5595.
26. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, Penke B, Zilberter Y, Harkany T, Pitkanen A, et al. 2009. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29:3453-3462.
27. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. 2000. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571-1577.
28. Naundorf B, Wolf F, Volgushev M. 2006. Unique features of action potential initiation in cortical neurons. Nature 440:1060-1063.
29. Oh MM, Oliveira FA, Disterhoft JF. 2010. Learning and aging related changes in intrinsic neuronal excitability. Front Aging Neurosci 2:2.
30. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, et al. 2007. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55:697-711.
31. Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V. 2007. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse 61:367-374.
32. Pimplikar SW. 2009. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int J Biochem Cell Biol 41:1261-1268.
33. Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. 2005. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25:6887-6897.
34. Randall AD, Booth C, Brown JT. 2012. Age-related changes to Na+ channel gating contribute to modified intrinsic neuronal excitability. Neurobiol Aging 33:2715-2720.
35. Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT. 2010. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 59:243-267.
36. Tamagnini F, Burattini C, Casoli T, Balietti M, Fattoretti P, Aicardi G. 2012. Early impairment of long-term depression in the perirhinal cortex of a mouse model of Alzheimer's disease. Rejuvenation Res 15:231-234.
37. Tamagnini F, Scullion S, Brown JT, Randall AD. 2014. Low concentrations of the solvent dimethyl sulphoxide alter intrinsic excitability properties of cortical and hippocampal pyramidal cells. PLoS One 9:e92557.
38. van Helmond Z, Miners JS, Kehoe PG, Love S. 2010. Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease. Brain Pathol 20:787-793.
39. Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, Devidze N, Masliah E, Kreitzer AC, Mody I, et al. 2012. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149:708-721.
40. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R. 2004. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24:3370-3378.
41. Waters J. 2010. The concentration of soluble extracellular amyloid-beta protein in acute brain slices from CRND8 mice. PLoS One 5:e15709.
42. Witton J, Brown JT, Jones MW, Randall AD. 2010. Altered synaptic plasticity in the mossy fibre pathway of transgenic mice expressing mutant amyloid precursor protein. Mol Brain 3:32.
43. Wykes R, Kalmbach A, Eliava M, Waters J. 2012. Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice. Neurobiol Aging 33:1609-1623.